Identification and quantification of HER2/neu as a proto-oncogene has led to humoral or antibody-based passive immunotherapy, including the use of trastuzumab (Herceptin®). The invention discussed in ...
REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- Inventprise, a clinical stage vaccine invention company, today announced the publication of a landmark preclinical study in Vaccine Journal (Vol. 54, ...
New York: A scientist of Indian origin has been named by Moderna as the primary contributor to its COVID-19 vaccine. A filing by the company for its patent application for the coronavirus vaccine ...
Indian Institute of Technology (IIT)-Bhubaneswar and the Institute of Life Sciences (ILS), Bhubaneswar, along with the National Research Development Corporation (NRDC), have signed a Quadripartite ...
BHUBANESWAR: Indian Institute of Technology (IIT) Bhubaneswar and Institute of Life Sciences (ILS) along with National Research Development Corporation (NRDC) on Monday signed a quadripartite licence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results